Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vidar Fykse, Arne Kristian Sandvik & Helge Lyder Waldum. (2005) One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release. Scandinavian Journal of Gastroenterology 40:11, pages 1269-1274.
Read now
Read now
R. Arnold, M. Frank, B. Simon, R. Eissele & H. Koop. (1992) Adaptation and Renewal of the Endocrine Stomach. Scandinavian Journal of Gastroenterology 27:sup193, pages 20-27.
Read now
Read now
H. F. Helander, K. Rutgersson, K. G. Helander, J. P. Pisegna, J. D Gardner, R. T. Jensen & P. N. Maton. (1992) Stereologic Investigations of Human Gastric Mucosa: II. Oxyntic Mucosa from Patients with Zollinger-Ellison Syndrome. Scandinavian Journal of Gastroenterology 27:10, pages 875-883.
Read now
Read now
Articles from other publishers (26)
Helge L. Waldum & Øystein F. Sørdal. (2016) Classification of Epithelial Malignant Tumors—the Differentiation Between Adenocarcinomas and Neuroendocrine Carcinomas. Applied Immunohistochemistry & Molecular Morphology 24:5, pages 309-312.
Crossref
Crossref
Sunil Dacha, Mohammed Razvi, Julia Massaad, Qiang Cai & Mohammad Wehbi. (2015) Hypergastrinemia. Gastroenterology Report 3:3, pages 201-208.
Crossref
Crossref
Krystallenia I. Alexandraki, Argiro Nikolaou, Dimitrios Thomas, Vassiliki Syriou, Penelope Korkolopoulou, Stavros Sougioultzis & Gregory Kaltsas. (2014) Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?. Clinical Endocrinology 80:5, pages 685-690.
Crossref
Crossref
Øystein Sørdal, Helge Waldum, Ivar S. Nordrum, Malcolm Boyce, Kåre Bergh, Bjørn Munkvold & Gunnar Qvigstad. (2013)
The Gastrin Receptor Antagonist Netazepide (YF476) Prevents Oxyntic Mucosal Inflammation Induced by
Helicobacter Pylori
Infection in Mongolian Gerbils
. Helicobacter 18:6, pages 397-405.
Crossref
Crossref
Bjørn K. Alsberg. (2012) Is sensing spatially distributed chemical information using sensory substitution with hyperspectral imaging possible?. Chemometrics and Intelligent Laboratory Systems 114, pages 24-29.
Crossref
Crossref
E. Hassall, D. Owen, W. Kerr, T. Sturby, P. Richardson & H. El-Serag. (2011) Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Alimentary Pharmacology & Therapeutics 33:7, pages 829-836.
Crossref
Crossref
L. LUNDELL, N. HAVU, P. MIETTINEN, H. E. MYRVOLD, L. WALLIN, R. JULKUNEN, K. LEVANDER, J. G. HATLEBAKK, B. LIEDMAN, M. LAMM, A. MALM & A. WALAN. (2006) Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Alimentary Pharmacology and Therapeutics 23:5, pages 639-647.
Crossref
Crossref
Paolo L. Peghini, Bruno Annibale, Cinzia Azzoni, Massimo Milione, Vito D. Corleto, Fathia Gibril, David J. Venzon, Gianfranco Delle Fave, Cesare Bordi & Robert T. Jensen. (2002) Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas. Gastroenterology 123:1, pages 68-85.
Crossref
Crossref
B. I. Hirschowitz & M. M. Haber. (2008)
Helicobacter pylori
effects on gastritis, gastrin and enterochromaffin‐like cells in Zollinger–Ellison syndrome and non‐Zollinger–Ellison syndrome acid hypersecretors treated long‐term with lansoprazole
. Alimentary Pharmacology & Therapeutics 15:1, pages 87-103.
Crossref
Crossref
Lars Lundell, Pekka Miettinen, Helge E. Myrvold, Sven A. Pedersen, Kjell Thor, Annelie Andersson, Jan Hattlebakk, Niilo Havu, Eero Janatuinen, Kristina Levander, Bengt Liedman & Per Nyström. (1999) Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 117:2, pages 319-326.
Crossref
Crossref
David M. Israel & Eric Hassall. (1998) Omeprazole and Other Proton Pump Inhibitors: Pharmacology, Efficacy, and Safety, with Special Reference to Use in Children. Journal of Pediatric Gastroenterology & Nutrition 27:5, pages 568-579.
Crossref
Crossref
B. Stoschus, G. Hamscher, S. Ikonomou, G. Partoulas, C. Eberle, T. Sauerbruch & G.E. Feurle. (2009) Effect of omeprazole treatment on plasma concentrations of the gastric peptides, xenin, gastrin and somatostatin, and of pepsinogen. The Journal of Peptide Research 52:1, pages 27-33.
Crossref
Crossref
Heidi‐Ingrid MaaroosNiilo HavuPentti Sipponen. (2001)
Follow‐Up of
Helicobacter pylori
Positive Gastritis and Argyrophil Cells Pattern During the Natural Course of Gastric Ulcer
. Helicobacter 3:1, pages 39-44.
Crossref
Crossref
Cesare Bordi, Bruno Annibale, Cinzia Azzoni, Massimo Marignani, Gabriella Ferraro, Giorgio Antonelli, Tiziana D'adda, Giancarlo D'ambra & Gianfranco Delle Fave. (1997) Endocrine cell growths in atrophic body gastritis. Critical evaluation of a histological classification. The Journal of Pathology 182:3, pages 339-346.
Crossref
Crossref
Michael F. Dixon, Robert M. Genta, John H. Yardley & Pelayo Correa. (1996) Classification and Grading of Gastritis. The American Journal of Surgical Pathology 20:10, pages 1161-1181.
Crossref
Crossref
Ernst J. Kuipers, Lars Lundell, Elly C. Klinkenberg-Knol, Niilo Havu, Henk P.M. Festen, Bengt Liedman, Cornelius B.H.W. Lamers, Jan B.M.J. Jansen, Jan Dalenbäck, Pleun Snel, G. Frits Nelis & Stephan G.M. Meuwissen. (1996)
Atrophic Gastritis and
Helicobacter pylori
Infection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication
. New England Journal of Medicine 334:16, pages 1018-1022.
Crossref
Crossref
E. J. KUIPERS, A. LEE, E. C. KLINKENBERG‐KNOL & S. G. M. MEUWISSEN. (2007) The development of atrophic gastritis—Helicobacter pylori and the effects of acid suppressive therapy. Alimentary Pharmacology & Therapeutics 9:4, pages 331-340.
Crossref
Crossref
U.G. Falkmer & S. Falkmer. (1995) The Value of Cytometric DNA Analysis as a Prognostic Tool in Neuroendocrine Neoplastic Diseases. Pathology - Research and Practice 191:4, pages 281-303.
Crossref
Crossref
R. F. McCloy, R. Arnold, K. D. Bardhan, D. Cattan, E. Klinkenberg-Knol, P. N. Maton, R. H. Riddell, P. Sipponen & A. Walan. (1995) Pathophysiological effects of long-term acid suppression in man. Digestive Diseases and Sciences 40:S2, pages 96S-120S.
Crossref
Crossref
James W. Freston, Kurt Borch, Stephen J. Brand, Enar Carlsson, W. Creutzfeldt, Rolf Håkanson, Lars Olbe, Enrico Solcia, John H. Walsh & M. Michael Wolfe. (1995) Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. Digestive Diseases and Sciences 40:S2, pages 50S-62S.
Crossref
Crossref
Bengt Hallerbäck, Peter Unge, Lasse Carling, Björn Edwin, Hans Glise, Nilu Havu, Ebbe Lyrenäs & Kjell Lundberg. (1994) Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 107:5, pages 1305-1311.
Crossref
Crossref
R. Lamberts. 1994. Ökosystem Darm VI. Ökosystem Darm VI
277
286
.
Regina Lamberts, Werner Creutzfeldt, Hans G. Strüber, Gorik Brunner & Enrico Solcia. (1993) Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:5, pages 1356-1370.
Crossref
Crossref
E. SOLCIA, L. VILLANI, O. LUINETT & R. FIOCCA. (2007) Proton pump inhibitors, enterochromaffin-like cell growth and Helicobacter pylori gastritis. Alimentary Pharmacology & Therapeutics 7, pages 25-28.
Crossref
Crossref
Enrico Solcia, Guido Rindi, Enrico Silini & Laura Villani. (1993) Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. Baillière's Clinical Gastroenterology 7:1, pages 149-165.
Crossref
Crossref
Herbert Koop, Margareta Frank, Simone Kuly, R�diger Nold, Rolf Eissele, Gudrun Rager, Josef R�schoff, Matthias Rothmund & Rudolf Arnold. (1993) Gastric argyrophil (enterochromaffin-like), gastrin, and somatostatin cells after proximal selective vagotomy in man. Digestive Diseases and Sciences 38:2, pages 295-302.
Crossref
Crossref